1. REsect: Blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization
2. SIRFLOX study Novel approach to defining the depth of response (DpR) within a volumetric model in patients with metastatic colorectal cancer (mCRC).
3. Assay variability in Antivirogram bioassay and proficiency testing to determine the gold standard.
4. Inventing control charts for the mega-variate data resulting from phenotypic and genotypic laboratory experiment.